The Abuse Potential of Remoxy<sup>®</sup>, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release OxycodoneBeatrice Setnik, Lynn R. Webster, Carl L. Roland et al.|Pain Medicine|2011Cited by 42
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendationsDennis C. Turk, Kerry Wolf, Richard A. Denisco et al.|Pain|2012Cited by 32
A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: A descriptive analysis of six patientsBeatrice Setnik, Lynn R. Webster, Carl L. Roland et al.|Journal of Opioid Management|2013Cited by 14
Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States cityBeatrice Setnik, Lynn R. Webster, Carl L. Roland et al.|Journal of Opioid Management|2015Cited by 14
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog ScalesBeatrice Setnik, Lynn R. Webster, Carl L. Roland et al.|The Journal of Clinical Pharmacology|2016Cited by 12